เข้าสู่ระบบ สมัครสมาชิก

quinoxaline การใช้

ประโยคมือถือ
  • It is isomeric with other naphthyridines including quinoxaline, phthalazine and quinazoline.
  • It is isomeric with other naphthyridines including quinoxaline, cinnoline and quinazoline.
  • It belongs to a family of quinoxaline antibiotics.
  • It is isomeric with the other diazanaphthalenes of the benzodiazine subgroup : cinnoline, quinoxaline, and phthalazine.
  • Caroverine is another closely related drug to the above, but instead containing a quinoxaline-2-one structure.
  • Although quinoxaline itself is mainly of academic interest, quinoxaline derivatives are used as dyes, pharmaceuticals, and antibiotics such as olaquindox, carbadox, echinomycin, levomycin and actinoleutin.
  • Although quinoxaline itself is mainly of academic interest, quinoxaline derivatives are used as dyes, pharmaceuticals, and antibiotics such as olaquindox, carbadox, echinomycin, levomycin and actinoleutin.
  • Caroverine [ 1-( diethylaminoethyl )-3  ( p-methoxybenzyl )  1, 2  hydroquinoxaline-2-one ] is a quinoxaline derivative developed in the 1960s.
  • Sirt6 deacetylation activity can be stimulated by high concentrations ( several hundred micromolar ) of fatty acids, and more potently by a first series of synthetic activators based on a pyrrolo [ 1, 2-a ] quinoxaline scaffold.
  • A "'quinoxaline "', also called a "'benzopyrazine "', in organic chemistry, is a heterocyclic compound containing a ring complex made up of a benzene ring and a pyrazine ring.
  • Some examples include developing ( a ) a continuous protocol for the two-carbon homologation of esters to prepare ( a ) ?-unsaturated esters with high yield and selectivity; ( b ) 2-functionalized phenols via benzyne-mediated in-line generation of arylmagnesium intermediates and aerobic oxidation; ( c ) developing a three-step continuous flow system which integrates in-line isocyanide formation and photochemical cyclization for preparing quinoxaline derivatives and ( d ) a two-step glycosylation and deprotection sequence to prepare 5-deoxyribonucleoside pharmaceuticals.